Coloplast : Acquisition of Atos Medical to enter field of laryngectomy
>Acquisition of Atos Medical - Coloplast has announced the acquisition of Atos Medical for a transaction price of € 2,155m (around DKK 16bn). The company was founded in 1986 and is the global market leader in laryngectomy. Previously, the company was owned by PAI Partners, a global private equity firm headquartered in Paris. On 1 October 2021, Atos Medical completed the acquisition of Tracoe. The acquisition will be structured as 100% cash-financed through debt finan...Coloplast is a supplier of intimate healthcare products and services. Co. develops and markets products that support people with diseases of a private nature. Co. operates in three business areas: Ostomy care, products for people whose intestinal outlet has been rerouted through the abdominal wall; Urology and continence care products, for people suffering from diseases of the kidneys, the urinary system and the male reproductive system; Dressings, for the treatment of chronic wounds and skin care products for prevention and treatment. Co. markets and sells its products and services globally. Co. supplies products to hospitals, institutions as well as wholesalers and retailers.
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.